VRDN — Viridian Therapeutics Inc
In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in Viridian Therapeutics Inc (VRDN), worth $32.56M combined. Over the quarter 5 opened or added, 0 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $14.12M | 0.02% | +278.4% |
| Emerald | $9.87M | 0.23% | NEW |
| Emerald Mutual | $7.27M | 0.26% | NEW |
| Quadrature | $828.08K | 0.00% | NEW |
| Persistent | $468.25K | 0.15% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.